This Biotech Stock Is Up 291% From Its IPO Price. It's On Pace for a Record Closing High.

This Biotech Stock Is Up 291% From Its IPO Price. It's On Pace for a Record Closing High.

来源:Barrons发布于 2026-11-16

CG Oncology stock is on pace for a record closing high after ‘best case' Phase 3 trial results for its bladder cancer treatment.

相关标的:CGON

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。